Indenopyrene and Blue-Light Co-Exposure Impairs the Tightly Controlled Activation of Xenobiotic Metabolism in Retinal Pigment Epithelial Cells: A Mechanism for Synergistic Toxicity.
Corinne ZinflouPatrick J RochettePublished in: International journal of molecular sciences (2023)
High energy visible (HEV) blue light is an increasing source of concern for visual health. Polycyclic aromatic hydrocarbons (PAH), a group of compounds found in high concentrations in smokers and polluted environments, accumulate in the retinal pigment epithelium (RPE). HEV absorption by indeno [1,2,3-cd]pyrene (IcdP), a common PAH, synergizes their toxicities and promotes degenerative changes in RPE cells comparable to the ones observed in age-related macular degeneration. In this study, we decipher the processes underlying IcdP and HEV synergic toxicity in human RPE cells. We found that IcdP-HEV toxicity is caused by the loss of the tight coupling between the two metabolic phases ensuring IcdP efficient detoxification. Indeed, IcdP/HEV co-exposure induces an overactivation of key actors in phase I metabolism. IcdP/HEV interaction is also associated with a downregulation of proteins involved in phase II. Our data thus indicate that phase II is hindered in response to co-exposure and that it is insufficient to sustain the enhanced phase I induction. This is reflected by an accelerated production of endogenous reactive oxygen species (ROS) and an increased accumulation of IcdP-related bulky DNA damage. Our work raises the prospect that lifestyle and environmental pollution may be significant modulators of HEV toxicity in the retina.
Keyphrases
- phase ii
- polycyclic aromatic hydrocarbons
- oxidative stress
- clinical trial
- dna damage
- induced apoptosis
- reactive oxygen species
- open label
- cell cycle arrest
- age related macular degeneration
- healthcare
- metabolic syndrome
- small molecule
- cell proliferation
- risk assessment
- human health
- particulate matter
- cell death
- endothelial cells
- signaling pathway
- type diabetes
- cardiovascular disease
- blood brain barrier
- physical activity
- electronic health record
- randomized controlled trial
- room temperature
- health information
- drug delivery
- machine learning
- weight loss
- ionic liquid
- climate change
- health risk assessment
- drinking water
- cancer therapy
- pi k akt